1-4 of 4
María Jesús Pascual, MD
Close
Sort by
Journal Articles

Post-Transplant Cyclophosphamide Versus MTX-CSA As Gvhd Prophylaxis in HLA-Identical Sibling HSCT

Rebeca Bailén, MD, Maria-Jesús Pascual, MD, Pascual Balsalobre, PhD, Anabel Gallardo-Morillo, MD, Abel García-Sola, MD, David Serrano, MD, Javier Anguita, MD PhD, Ismael Buño, PhD, Nieves Dorado Herrero, MD, Laura Solán, PhD, Jose Díez-Martín, MD PhD, Mi Kwon
Journal: Blood
Blood (2018) 132 (Supplement 1): 3394.
https://doi.org/10.1182/blood-2018-99-110551
Published: 2018
Journal Articles

Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Mariana Bastos-Oreiro, MD, Pascual Balsalobre, PhD, Diana Champ, MD, Juan Churruca, MD, Maria Jesus Pascual, MD, Pilar Herrera, MD, Leyre Bento, MD, Jose Luis Piñana, MD, Santiago Jimenez, MD, Karem Humala, MD, Pau Montesinos, MD, Inmaculada Heras, MD, Almudena Iglesias, MD, Ana Perez-Corral, MD, Cristina Pascual, MD, Carolina Martinez-Laperche, PhD, Mi Kwon, MD, Jorge Gayoso, MD, Jose L. Diez-Martin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3131.
https://doi.org/10.1182/blood.V126.23.3131.3131
Published: 2015
Journal Articles

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Reduced Intensity Conditioning (RIC) Regimens and High Dose Cylophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In Patients With Relapsed Or Refractory Hodgkin´s Disease: Multicentric Spanish Experience

Jorge Gayoso, MD, Pascual Balsalobre, MSc, Cristina Castilla-Llorente, MD, María Jesús Pascual, MD, Mi Kwon, MD, David Serrano, MD, Dolores Caballero, MD, PhD, Jose Antonio Pérez-Simón, Arancha Bermudez, MD, Carmen Martínez, MD, Cristina Pascual, MD, Inmaculada Heras, Carlos Solano, Angela Figuera, MD, Antonia Sampol, MD, PhD, Christelle Ferra, MD, Pilar Herrera, Ismael Buno, PhD, Jose Luis Diez-Martin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3406.
https://doi.org/10.1182/blood.V122.21.3406.3406
Published: 2013
Journal Articles

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With High Dose Cyclophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In High Risk Hematologic Malignancies: Multicentric Spanish Experience

Jorge Gayoso, MD, Pascual Balsalobre, MSc, Mi Kwon, MD, María Jesús Pascual, MD, Cristina Castilla-Llorente, MD; PhD, David Serrano, MD, Dolores Caballero, MD, PhD, Jose Antonio Pérez-Simón, Arancha Bermudez, MD, Montserrat Rovira, MD, Javier Anguita, MD, Ana Pérez-Corral, MD, Inmaculada Heras, Carlos Solano, MD, Angela Figuera, MD; PhD, Antonia Sampol, MD, Christelle Ferra, MD, Pilar Herrera, Marta Sonia González, MD, Pau Montesinos, Ismael Buno, PhD, Jose Luis Diez-Martin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2173.
https://doi.org/10.1182/blood.V122.21.2173.2173
Published: 2013